+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Implantable Drug Delivery Device Market Research Report by Product, Technology, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4904899
  • Report
  • April 2022
  • Region: Global
  • 203 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Abbott
  • Auro lab
  • CME Medical UK Limited
  • EyeKon Medical Inc.
  • Lenstec Inc.
  • Moog Inc.
The Global Implantable Drug Delivery Device Market size was estimated at USD 16.74 billion in 2021, USD 18.19 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.81% to reach USD 27.79 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Implantable Drug Delivery Device to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Bio-absorbable Stent, Brachytherapy Seeds, Coronary Drug-eluting Stent, Drug Infusion Pumps, Implantable Contraceptive Devices, and Implantable Intraocular Devices.
  • Based on Technology, the market was studied across Bio-degradable, Non-biodegradable, and Smart Pills.
  • Based on Application, the market was studied across Cardiology, Contraceptive, Oncology, and Ophthalmology.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Implantable Drug Delivery Device market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Implantable Drug Delivery Device Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Implantable Drug Delivery Device Market, including Abbott, Alimera Sciences, Allergan, Auro lab, Baxter International Inc., Bayer AG, Boston Scientific Corporation, CME Medical UK Limited, Delpor Inc., DSM Biomedical, EyeKon Medical Inc., Eyepoint Pharmaceuticals, Johnson & Johnson,, Lenstec Inc., Medtronic, Merck & Co., Inc, Moog Inc., Pfizer Inc, Reckitt Benckiser Group Plc, Smiths Medical, Tandem Diabetes Care, Inc., Teleflex Incorporated, Teva Pharmaceuticals Industries Ltd., Valeant Pharmaceuticals, and Veru Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Implantable Drug Delivery Device Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Implantable Drug Delivery Device Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Implantable Drug Delivery Device Market?
4. What is the competitive strategic window for opportunities in the Global Implantable Drug Delivery Device Market?
5. What are the technology trends and regulatory frameworks in the Global Implantable Drug Delivery Device Market?
6. What is the market share of the leading vendors in the Global Implantable Drug Delivery Device Market?
7. What modes and strategic moves are considered suitable for entering the Global Implantable Drug Delivery Device Market?
Frequently Asked Questions about the Global Implantable Drug Delivery Device Market

What is the estimated value of the Global Implantable Drug Delivery Device Market?

The Global Implantable Drug Delivery Device Market was estimated to be valued at $16.7 Billion in 2021.

What is the growth rate of the Global Implantable Drug Delivery Device Market?

The growth rate of the Global Implantable Drug Delivery Device Market is 8.8%, with an estimated value of $27.8 Billion by 2027.

What is the forecasted size of the Global Implantable Drug Delivery Device Market?

The Global Implantable Drug Delivery Device Market is estimated to be worth $27.8 Billion by 2027.

Who are the key companies in the Global Implantable Drug Delivery Device Market?

Key companies in the Global Implantable Drug Delivery Device Market include Abbott, Alimera Sciences, Allergan, Auro lab, Baxter International Inc., Bayer AG, Boston Scientific Corporation, CME Medical UK Limited and DSM Biomedical.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Auro lab
  • CME Medical UK Limited
  • EyeKon Medical Inc.
  • Lenstec Inc.
  • Moog Inc.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of chronic conditions, such as cancer and diabetes
5.1.1.2. Advances in medication administration techniques
5.1.1.3. Adoption of infusion pumps to monitor patient safety and avoid frequent dosage errors
5.1.2. Restraints
5.1.2.1. High cost of devices
5.1.3. Opportunities
5.1.3.1. Growing adoption of specialty infusion systems
5.1.3.2. Rising amalgamation activities for advancement in implantable drug delivery device
5.1.4. Challenges
5.1.4.1. Noticeable incidences of product recall due to medical error
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Implantable Drug Delivery Device Market, by Product
6.1. Introduction
6.2. Bio-absorbable Stent
6.3. Brachytherapy Seeds
6.4. Coronary Drug-eluting Stent
6.5. Drug Infusion Pumps
6.6. Implantable Contraceptive Devices
6.7. Implantable Intraocular Devices
7. Implantable Drug Delivery Device Market, by Technology
7.1. Introduction
7.2. Bio-degradable
7.3. Non-biodegradable
7.4. Smart Pills
8. Implantable Drug Delivery Device Market, by Application
8.1. Introduction
8.2. Cardiology
8.3. Contraceptive
8.4. Oncology
8.5. Ophthalmology
9. Americas Implantable Drug Delivery Device Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Implantable Drug Delivery Device Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Implantable Drug Delivery Device Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott
13.2. Alimera Sciences
13.3. Allergan
13.4. Auro lab
13.5. Baxter International Inc.
13.6. Bayer AG
13.7. Boston Scientific Corporation
13.8. CME Medical UK Limited
13.9. Delpor Inc.
13.10. DSM Biomedical
13.11. EyeKon Medical Inc.
13.12. Eyepoint Pharmaceuticals
13.13. Johnson & Johnson,
13.14. Lenstec Inc.
13.15. Medtronic
13.16. Merck & Co., Inc
13.17. Moog Inc.
13.18. Pfizer Inc
13.19. Reckitt Benckiser Group Plc
13.20. Smiths Medical
13.21. Tandem Diabetes Care, Inc.
13.22. Teleflex Incorporated
13.23. Teva Pharmaceuticals Industries Ltd.
13.24. Valeant Pharmaceuticals
13.25. Veru Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET: DYNAMICS
FIGURE 2. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 3. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2027
FIGURE 5. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-ABSORBABLE STENT, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-ABSORBABLE STENT, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BRACHYTHERAPY SEEDS, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BRACHYTHERAPY SEEDS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CORONARY DRUG-ELUTING STENT, 2019-2027 (USD BILLION)
FIGURE 10. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CORONARY DRUG-ELUTING STENT, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 11. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG INFUSION PUMPS, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG INFUSION PUMPS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE CONTRACEPTIVE DEVICES, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE CONTRACEPTIVE DEVICES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE INTRAOCULAR DEVICES, 2019-2027 (USD BILLION)
FIGURE 16. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE INTRAOCULAR DEVICES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 18. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD BILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 20. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-DEGRADABLE, 2019-2027 (USD BILLION)
FIGURE 21. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-DEGRADABLE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 22. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY NON-BIODEGRADABLE, 2019-2027 (USD BILLION)
FIGURE 23. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY NON-BIODEGRADABLE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY SMART PILLS, 2019-2027 (USD BILLION)
FIGURE 25. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY SMART PILLS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 27. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2027
FIGURE 29. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CARDIOLOGY, 2019-2027 (USD BILLION)
FIGURE 30. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 31. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CONTRACEPTIVE, 2019-2027 (USD BILLION)
FIGURE 32. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CONTRACEPTIVE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 33. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD BILLION)
FIGURE 34. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 35. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY OPHTHALMOLOGY, 2019-2027 (USD BILLION)
FIGURE 36. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 37. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 38. ARGENTINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 39. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 40. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 41. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 42. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 43. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. INDONESIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. MALAYSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. PHILIPPINES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. SINGAPORE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 53. TAIWAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. THAILAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. NETHERLANDS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. QATAR IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. UNITED ARAB EMIRATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 67. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET: FPNV POSITIONING MATRIX
FIGURE 68. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-ABSORBABLE STENT, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-ABSORBABLE STENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-ABSORBABLE STENT, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-ABSORBABLE STENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-ABSORBABLE STENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BRACHYTHERAPY SEEDS, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BRACHYTHERAPY SEEDS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BRACHYTHERAPY SEEDS, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BRACHYTHERAPY SEEDS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BRACHYTHERAPY SEEDS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CORONARY DRUG-ELUTING STENT, BY REGION, 2019-2027 (USD BILLION)
TABLE 15. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CORONARY DRUG-ELUTING STENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CORONARY DRUG-ELUTING STENT, BY STATE, 2019-2027 (USD BILLION)
TABLE 17. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CORONARY DRUG-ELUTING STENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CORONARY DRUG-ELUTING STENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG INFUSION PUMPS, BY REGION, 2019-2027 (USD BILLION)
TABLE 20. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG INFUSION PUMPS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG INFUSION PUMPS, BY STATE, 2019-2027 (USD BILLION)
TABLE 22. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG INFUSION PUMPS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG INFUSION PUMPS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE CONTRACEPTIVE DEVICES, BY REGION, 2019-2027 (USD BILLION)
TABLE 25. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE CONTRACEPTIVE DEVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE CONTRACEPTIVE DEVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 27. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE CONTRACEPTIVE DEVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE CONTRACEPTIVE DEVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE INTRAOCULAR DEVICES, BY REGION, 2019-2027 (USD BILLION)
TABLE 30. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE INTRAOCULAR DEVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE INTRAOCULAR DEVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 32. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE INTRAOCULAR DEVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE INTRAOCULAR DEVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
TABLE 35. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-DEGRADABLE, BY REGION, 2019-2027 (USD BILLION)
TABLE 36. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-DEGRADABLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 37. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-DEGRADABLE, BY STATE, 2019-2027 (USD BILLION)
TABLE 38. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-DEGRADABLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-DEGRADABLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 40. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY NON-BIODEGRADABLE, BY REGION, 2019-2027 (USD BILLION)
TABLE 41. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY NON-BIODEGRADABLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY NON-BIODEGRADABLE, BY STATE, 2019-2027 (USD BILLION)
TABLE 43. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY NON-BIODEGRADABLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY NON-BIODEGRADABLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY SMART PILLS, BY REGION, 2019-2027 (USD BILLION)
TABLE 46. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY SMART PILLS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY SMART PILLS, BY STATE, 2019-2027 (USD BILLION)
TABLE 48. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY SMART PILLS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY SMART PILLS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 51. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 52. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 53. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CARDIOLOGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 54. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 56. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CONTRACEPTIVE, BY REGION, 2019-2027 (USD BILLION)
TABLE 57. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CONTRACEPTIVE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 58. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CONTRACEPTIVE, BY STATE, 2019-2027 (USD BILLION)
TABLE 59. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CONTRACEPTIVE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CONTRACEPTIVE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 61. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 62. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 63. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 64. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 66. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2019-2027 (USD BILLION)
TABLE 67. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 68. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY OPHTHALMOLOGY, BY STATE, 2019-2027 (USD BILLION)
TABLE 69. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 71. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 72. ARGENTINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 73. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 74. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 75. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 76. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 77. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 78. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 79. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 80. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 81. INDONESIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 82. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 83. MALAYSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 84. PHILIPPINES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 85. SINGAPORE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 86. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 87. TAIWAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 88. THAILAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 90. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 91. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 92. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 93. NETHERLANDS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 94. QATAR IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 95. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 96. SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 97. SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 98. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 99. UNITED ARAB EMIRATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 100. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 101. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET: SCORES
TABLE 102. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET: BUSINESS STRATEGY
TABLE 103. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET: PRODUCT SATISFACTION
TABLE 104. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET: RANKING
TABLE 105. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 106. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET: MERGER & ACQUISITION
TABLE 107. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 108. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 109. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET: INVESTMENT & FUNDING
TABLE 110. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 111. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott
  • Alimera Sciences
  • Allergan
  • Auro lab
  • Baxter International Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • CME Medical UK Limited
  • Delpor Inc.
  • DSM Biomedical
  • EyeKon Medical Inc.
  • Eyepoint Pharmaceuticals
  • Johnson & Johnson,
  • Lenstec Inc.
  • Medtronic
  • Merck & Co., Inc
  • Moog Inc.
  • Pfizer Inc
  • Reckitt Benckiser Group Plc
  • Smiths Medical
  • Tandem Diabetes Care, Inc.
  • Teleflex Incorporated
  • Teva Pharmaceuticals Industries Ltd.
  • Valeant Pharmaceuticals
  • Veru Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...